Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01HKL
|
|||
Former ID |
DNCL002936
|
|||
Drug Name |
ABT-335
|
|||
Synonyms |
Choline fenofibrate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Dyslipidemia [ICD-11: 5C80-5C81; ICD-9: 272] | Approved | [1] | |
Company |
Abbott Laboratories
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H28ClNO5
|
|||
Canonical SMILES |
CC(C)(C(=O)[O-])OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl.C[N+](C)(C)CCO
|
|||
InChI |
1S/C17H15ClO4.C5H14NO/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11;1-6(2,3)4-5-7/h3-10H,1-2H3,(H,20,21);7H,4-5H2,1-3H3/q;+1/p-1
|
|||
InChIKey |
JWAZHODZSADEHB-UHFFFAOYSA-M
|
|||
CAS Number |
CAS 856676-23-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ADReCS Drug ID | BADD_D00455 | |||
SuperDrug ATC ID |
C10AB11
|
References | Top | |||
---|---|---|---|---|
REF 1 | Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study. Am Heart J. 2009 Jan;157(1):195-203. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.